FDA Grants Fast Track Designation to Bristol Myers Squibb’s Alzheimer’s Antibody BMS-986446 Read more
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients Read more
Novartis’ Rhapsido Approved by FDA as First Oral BTK Inhibitor for Chronic Spontaneous Urticaria Read more